Matthew Powner: Origin Solver

Lecturer, Department of Chemistry, University College London. Age: 32

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© ELAINE PERKSMatthew Powner studied chemistry at the University of Manchester in large part because he was good at it. “I think it felt like the path of least resistance,” he says. But then he discovered organic chemistry, and its pictorial style of problem solving captured Powner’s imagination.

In organic chemist David Proctor’s lab during his fourth year at Manchester, Powner developed tools for building organic molecules that would react with a compound called samarium iodide to form a specific chemical architecture. He graduated with both his bachelor’s and master’s degrees in the spring of 2005 and, after a summer internship at nearby AstraZeneca, he returned to Manchester to earn his PhD under chemist John Sutherland. While Sutherland hadn’t been at the top of Powner’s list of possible Manchester advisors, it didn’t take long for the renowned origins-of-life researcher to reel Powner in. “I’d always thought of organic chemistry as a tool [for designing new compounds], but John made me think about whether we could use organic chemistry to think about why the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo